Data Licensing Pricing: Examples & Companies

4 companies in the corpus Updated stub analysis
Definition

Data Licensing Pricing is a pricing structure where access to proprietary datasets or data assets is licensed separately from the software or services, common in AI training data and clinical data platforms.

Also known as: Dataset License PricingData Access Pricing

What is it

Data Licensing Pricing is a pricing structure where access to proprietary datasets or data assets is licensed separately from the software or services, common in AI training data and clinical data platforms.

Unlike per-token or per-API-call pricing — where the customer pays for compute a model performs — data licensing charges for the underlying data itself: a curated corpus of labeled examples, a multimodal clinical database, or an expert-annotated training set. The licensed asset is typically fixed or periodically refreshed, and the contract governs what the buyer may do with it (train models, publish findings, redistribute) rather than how many times they query a service.

The category sits at the intersection of software and content economics. Software vendors like Labelbox and Snorkel AI layer data-licensing contracts on top of platform subscriptions, selling curated datasets as a premium product that complements their tooling — Snorkel’s Expert Data-as-a-Service delivers scoped expert datasets to frontier labs as committed deliverables. Healthcare AI companies like Tempus run the model in reverse: the diagnostics business generates the data asset, which is then licensed to pharma under multi-year deals as the high-margin revenue engine.

Buyers here are typically frontier AI labs, pharmaceutical companies, and enterprises with proprietary model-development ambitions. They pay premium prices for data that is hard or impossible to replicate: expert-annotated training sets, de-identified patient records with linked outcomes, or specialized evaluation datasets. Scale AI built a data business on exactly this scarcity — it publishes no rate card, and enterprise customers cannot benchmark a quote without an RFP because the data asset is unique.

One dataset, four licenses — mostly sales-quoted, always high-margin
The data asset is built once — then licensed at near-zero marginal cost PUBLISHED METER $0.10 Labelbox · per LBU SALES-QUOTED ~$60k Snorkel · est. only NO RATE CARD RFP only Scale AI · book a demo MULTI-YEAR DEAL $1.1B+ Tempus · pharma TCV ← PUBLISHED CUSTOM-CONTRACTED → TEMPUS GROSS MARGIN Build data · ~48% License data · ~77%

How it works

A data-licensing deal has several structural dimensions that together define what the buyer gets and what they pay. Unlike metered billing — where the invoice reflects usage after the fact — most data licenses are negotiated upfront as committed contracts, with the total fee scoped against the variables below:

DimensionWhat it controlsExample
Data scopeThe modalities, domains, and volume covered by the licenseTempus licenses de-identified multimodal oncology data (genomic + clinical + imaging) to pharma under contracts scoped to specific therapeutic areas
Access modelWhether the buyer gets a static snapshot, an ongoing feed, or query-based accessSnorkel Expert Data-as-a-Service delivers scoped expert datasets as committed deliverables rather than a per-record meter
Usage rightsWhat the buyer may do with the data — train models, publish, redistributeData-licensing contracts routinely restrict redistribution and require audit rights; Tempus’s pharma agreements bundle model-development rights for specific oncology programs
Contract termAnnual, multi-year, or milestone-gatedSnorkel AI’s expert-data contracts are annual committed subscriptions; Tempus’s AstraZeneca/Pathos deal runs ~3 years for $200M
Volume floorMinimum data volume or spend commitmentMost enterprise data licenses carry a committed floor; there is no pay-as-you-go data license at scale

Unit math: Total data-license fee = (data scope × domain premium) + (model-development milestone fees) + (annual renewal × contracted term). Unlike a software subscription, the fee is usually not divisible by a per-record rate — it is a negotiated total based on perceived data scarcity and buyer need.

The economics are asymmetric. Producing the data (labeling, sequencing, curation) is capital-intensive and low-margin; licensing it to additional buyers is high-margin because the marginal cost of delivering another copy is near zero. Tempus shows the split cleanly: its genomics business runs at roughly 48% gross margin while data & services — the licensing line, which reached about $316M of revenue in FY2025 — runs near 77%. Snorkel AI grew ARR from $36.8M in 2024 to roughly $148M in 2025 largely by expanding its expert data-licensing contracts with frontier labs. Choosing which dimension to meter is itself a strategy decision — see the guide to choosing the right usage metric.

Pricing is almost universally sales-quoted rather than published. Scale AI routes every inquiry to “book a demo,” and third-party estimates (roughly $0.02 per image and $0.06 per annotation for self-serve, average contract near $93K/year) are not an official rate card. Labelbox is the one exception with a published software meter — its Starter tier is $0.10 per Labelbox Unit (LBU) — though its managed human-data services stay sales-quoted. Snorkel AI publishes nothing; a $60,000 AWS Marketplace 12-month hosted-application contract is the only concrete public figure, with enterprise deals described as six-figure annually. For how usage-based billing cycles work in data-intensive businesses, see the guide to usage invoicing and billing cycles.


Companies using this

Four companies in the corpus license data as a billing unit. Tempus anchors the clinical end, with a pharma data-licensing line whose total contract value passed $1.1 billion by end-2025; Scale AI, Labelbox, and Snorkel AI sell AI training data. Only Labelbox exposes a self-serve rate; the rest are sales-quoted.

Company Product Pricing modelBilling unitsFree tier Verified
LabelboxAI training-data platform (data labeling, curation & model evaluation)Yes2026-06-15
Scale AIData engine, GenAI platform & contributor marketplaceNo2026-06-15
Snorkel AIProgrammatic AI data development platform & expert dataNo2026-07-23
TempusPrecision-medicine platform — genomic diagnostics, multimodal clinical data licensing & oncology AI apps (NASDAQ: TEM)No2026-06-10

Explore this theme in the knowledge graph

FAQ

What is data licensing pricing?

Data licensing pricing is a structure where a vendor charges a separate fee for access to a proprietary dataset or data asset, distinct from any software subscription or per-task fee. The license defines the scope of access — a defined snapshot, an ongoing feed, or a custom extraction — and typically bakes usage restrictions and audit rights into the contract.

How do AI training data companies price data licenses?

Most AI training data companies price data licenses through enterprise sales-quoted, multi-year committed contracts rather than a public per-record rate. Scale AI and Snorkel AI both sell expert data via bespoke annual contracts; Tempus licenses de-identified clinical multimodal data to pharma partners under multi-year deals whose total contract value passed $1.1 billion by end-2025. Labelbox is the exception, with a published self-serve software meter ($0.10 per Labelbox Unit), though its managed human-data services stay sales-quoted.

Is data licensing pricing published or sales-quoted?

It is almost always sales-quoted. Scale AI and Snorkel AI publish no rate card and route buyers to 'book a demo'; Tempus's pharma data agreements are custom multi-year contracts measured in total contract value, not per-unit price. Third-party estimates exist (for example a $60,000 AWS Marketplace 12-month Snorkel contract) but are indicative, not official.

Why is data licensing so high-margin?

Producing the data — labeling, sequencing, curation — is capital-intensive and low-margin, but licensing an existing dataset to additional buyers costs almost nothing at the margin. Tempus illustrates the split: its genomics line runs at roughly 48% gross margin while its data & services line runs near 77%.

Related billing units

Back to companies